Exposure–response modeling for nausea incidence for cotadutide using a Markov modeling approach
Abstract Cotadutide is a dual glucagon‐like peptide‐1 (GLP‐1)/glucagon receptor agonist. Gastrointestinal adverse effects are known to be associated with GLP‐1 receptor agonism and can be mitigated through tolerance development via a gradual up‐titration. This analysis aimed to characterize the rela...
Spremljeno u:
| Glavni autori: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wiley
2024-09-01
|
| Serija: | CPT: Pharmacometrics & Systems Pharmacology |
| Online pristup: | https://doi.org/10.1002/psp4.13194 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
